Literature DB >> 24785685

Plasma Homocysteine is Associated with Retinopathy in Type 1 Diabetic Patients in the Absence of Nephropathy.

Tomislav Bulum1, Kristina Blaslov1, Lea Duvnjak1.   

Abstract

INTRODUCTION: Previous cross-sectional studies suggested that plasma total homocysteine (tHcy) is associated with retinopathy in patients with type 1 diabetes (T1DM) only in cases of impaired renal function. The objective of this study was to examine whether there is an independent relationship between tHcy and retinopathy in normoalbuminuric T1DM patients with normal estimated glomerular filtration rate (eGFR).
METHODS: The study included 163 normoalbuminuric patients with T1DM and normal renal function (eGFR >60 ≤ 125 ml min(-1) 1.73 m(-2)). Urinary albumin excretion rate (UAE) was measured from at least two 24 h urine samples. Photodocumented retinopathy status was made according to the EURODIAB protocol. tHcy level was measured with the chemiluminescent immunoassay.
RESULTS: Retinopathy was present in 48% of normoalbuminuric patients. Patients with retinopathy were older (49 vs 42 years, p = 0.001), had higher systolic blood pressure (130 vs 120 mmHg, p = 0.001), triglycerides (0.89 vs 0.77 mmol/L, p = 0.01), tHcy (9.8 vs 9.1 µmol/L, p = 0.04), and lower eGFR (100 vs 106 ml min(-1) 1.73 m(-2), p = 0.03). In multivariate logistic regression analysis, after adjustment for variables that reached statistical significance in the univariate analysis, only tHcy was significantly associated with a risk of retinopathy in our subjects (p = 0.02), with odds ratios of 1.02 to 1.43.
CONCLUSION: These data suggest that tHcy is independently associated with retinopathy in normoalbuminuric T1DM with normal eGFR. The mechanisms relating tHcy and retinopathy in T1DM are not clear. Prospectives studies are needed to confirm whether higher tHcy in normoalbuminuric T1DM patients has predictive value for development of retinopathy.

Entities:  

Keywords:  Homocysteine; microvascular complications; retinopathy; type 1 diabetes

Mesh:

Substances:

Year:  2014        PMID: 24785685     DOI: 10.3109/08820538.2014.912338

Source DB:  PubMed          Journal:  Semin Ophthalmol        ISSN: 0882-0538            Impact factor:   1.975


  7 in total

1.  Association between plasma homocysteine and progression of early nephropathy in type 2 diabetic patients.

Authors:  Huan Wang; Kai Cui; Ke Xu; Shixin Xu
Journal:  Int J Clin Exp Med       Date:  2015-07-15

Review 2.  Biomarkers in Diabetic Retinopathy.

Authors:  Alicia J Jenkins; Mugdha V Joglekar; Anandwardhan A Hardikar; Anthony C Keech; David N O'Neal; Andrzej S Januszewski
Journal:  Rev Diabet Stud       Date:  2015-08-10

3.  Association of homocysteine with type 1 diabetes mellitus: a meta-analysis.

Authors:  Yu Feng; Mei-Qin Shan; Lin Bo; Xiao-Yan Zhang; Ji Hu
Journal:  Int J Clin Exp Med       Date:  2015-08-15

4.  Analysis of MTHFR, CBS, Glutathione, Taurine, and Hydrogen Sulfide Levels in Retinas of Hyperhomocysteinemic Mice.

Authors:  Xuezhi Cui; Soumya Navneet; Jing Wang; Penny Roon; Wei Chen; Ming Xian; Sylvia B Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-04-01       Impact factor: 4.799

5.  Faulty homocysteine recycling in diabetic retinopathy.

Authors:  Renu A Kowluru; Ghulam Mohammad; Nikhil Sahajpal
Journal:  Eye Vis (Lond)       Date:  2020-01-10

Review 6.  Association between homocysteine level and the risk of diabetic retinopathy: a systematic review and meta-analysis.

Authors:  Xunwen Lei; Guifeng Zeng; Yuemei Zhang; Qiang Li; Jinzhi Zhang; Zhenggang Bai; Kehu Yang
Journal:  Diabetol Metab Syndr       Date:  2018-08-02       Impact factor: 3.320

Review 7.  Diabetic Retinopathy: Mitochondria Caught in a Muddle of Homocysteine.

Authors:  Renu A Kowluru
Journal:  J Clin Med       Date:  2020-09-19       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.